System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma
Background Immune checkpoint inhibitors as monotherapies for advanced hepatocellular carcinoma (HCC) fail to achieve satisfying results, while combination therapies show greater efficacy. Therefore, identifying new combined targets for immune checkpoint inhibitors could be promising.Methods We combi...
Saved in:
| Main Authors: | Yu Wang, Yong Yang, Xu Wang, Xinying Tang, Tao Zhou, Haoyu Wang, Xingyi Chen, Yushi Ding, Haoyang Tu, Shengyang Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/3/e004414.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPIH associated with immune infiltrates and immunotherapy response in hepatocellular carcinoma
by: Haini Chen, et al.
Published: (2025-04-01) -
ZNF165 Is Involved in the Regulation of Immune Microenvironment and Promoting the Proliferation and Migration of Hepatocellular Carcinoma by AhR/CYP1A1
by: Peng Liu, et al.
Published: (2022-01-01) -
Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances
by: Dong Xie, et al.
Published: (2025-04-01) -
A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01) -
Future perspectives on immunotherapy for hepatocellular carcinoma
by: Landon L. Chan, et al.
Published: (2025-03-01)